SC 13G: Rapport Therapeutics, Inc.

Ticker: RAPP · Form: SC 13G · Filed: Jun 21, 2024 · CIK: 2012593

Rapport Therapeutics, Inc. SC 13G Filing Summary
FieldDetail
CompanyRapport Therapeutics, Inc. (RAPP)
Form TypeSC 13G
Filed DateJun 21, 2024
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: sc-13g

AI Summary

SC 13G filing by Rapport Therapeutics, Inc..

Risk Assessment

Risk Level: low

FAQ

What type of filing is this?

This is a SC 13G filing submitted by Rapport Therapeutics, Inc. (ticker: RAPP) to the SEC on Jun 21, 2024.

What is the risk level of this SC 13G filing?

This filing has been assessed as low risk.

Where can I view the full SC 13G filing?

The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.

Filing Details

This Form SC 13G (Form SC 13G) was filed with the SEC on June 21, 2024 regarding Rapport Therapeutics, Inc. (RAPP).

View full filing on EDGAR

View Full Filing

View this SC 13G filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.